Comparison of 5-Aminolevulinic Acid Photodynamic Therapy and Clobetasol Propionate in Treatment of Vulvar Lichen Sclerosus
DOI:
https://doi.org/10.2340/00015555-2341Abstract
The aim of this study was to evaluate the effectiveness of 5-aminolevulinic acid photodynamic therapy (ALA-PDT) for the treatment of vulvar lichen sclerosus (VLS) and compare its effectiveness with that of clobetasol propionate. Four sessions of topical photodynamic therapy (PDT) were administered at 2-week intervals (n=20). Clobetasol propionate (0.05%) was used daily for 8 weeks (n=20). The rate of complete response in the PDT group (14/20) was double that of the clobetasol propionate group (7/20) (p<0.05, –2=4.912). Horizontal visual analogue scores indicated that PDT was more effective than clobetasol propionate. Pain intensity numeric rating scale values for PDT were between 3.05 and 4.45. One month after the final session of PDT, only one patient relapsed and all 7 patients in clobetasol propionate group relapsed. ALA-PDT is a well-tolerated and effective option for the treatment of VLS.Downloads
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2016 Lei Shi, Fei Miao, Ling-Lin Zhang, Guo-Long Zhang, Pei-Ru Wang, Jie Ji, Xiao-Jie Wang, Zheng Huang, Hong-Wei Wang, Xiu-Li Wang
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
